Singular Genomics Sys Analyst Ratings
Singular Genomics Sys Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/10/2023 | 42.65% | Goldman Sachs | $1.15 → $1 | Maintains | Neutral |
11/08/2022 | 327.96% | Goldman Sachs | $3.5 → $3 | Maintains | Neutral |
08/17/2022 | 541.94% | UBS | $10 → $4.5 | Downgrades | Buy → Neutral |
08/10/2022 | 327.96% | B of A Securities | → $3 | Downgrades | Buy → Underperform |
08/10/2022 | 399.29% | Goldman Sachs | → $3.5 | Downgrades | Buy → Neutral |
07/14/2022 | 613.27% | Goldman Sachs | $9.5 → $5 | Maintains | Buy |
05/11/2022 | 1255.21% | Goldman Sachs | $11 → $9.5 | Maintains | Buy |
04/13/2022 | 1469.19% | Goldman Sachs | $17 → $11 | Maintains | Buy |
01/07/2022 | 2895.72% | B of A Securities | → $21 | Upgrades | Neutral → Buy |
06/21/2021 | 3608.99% | B of A Securities | → $26 | Initiates Coverage On | → Neutral |
06/21/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
06/21/2021 | 4179.6% | JP Morgan | → $30 | Initiates Coverage On | → Overweight |
06/21/2021 | 4892.87% | Goldman Sachs | → $35 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
2023年08月10日 | 42.65% | 高盛 | $1.15→$1 | 維護 | 中性 |
11/08/2022 | 327.96% | 高盛 | $3.5→$3 | 維護 | 中性 |
2022/08/17 | 541.94% | 瑞銀集團 | $10→$4.5 | 評級下調 | 購買→中性 |
2022年08月10日 | 327.96% | B of A證券 | →$3 | 評級下調 | 購買表現不佳的→ |
2022年08月10日 | 399.29% | 高盛 | →$3.5 | 評級下調 | 購買→中性 |
07/14/2022 | 613.27% | 高盛 | $9.5→$5 | 維護 | 買 |
2022年05月11日 | 1255.21% | 高盛 | $11→$9.5 | 維護 | 買 |
04/13/2022 | 1469.19% | 高盛 | $17→$11 | 維護 | 買 |
01/07/2022 | 2895.72% | B of A證券 | →$21 | 升級 | 中性→購買 |
2021/06/21 | 3608.99% | B of A證券 | →$26 | 開始承保 | →中性 |
2021/06/21 | - | 考恩公司 | 開始承保 | →跑贏大盤 | |
2021/06/21 | 4179.6% | 摩根大通 | →$30 | 開始承保 | →超重 |
2021/06/21 | 4892.87% | 高盛 | →$35 | 開始承保 | →購買 |
What is the target price for Singular Genomics Sys (OMIC)?
Single Genology Sys(OMIC)的目標價格是多少?
The latest price target for Singular Genomics Sys (NASDAQ: OMIC) was reported by Goldman Sachs on August 10, 2023. The analyst firm set a price target for $1.00 expecting OMIC to rise to within 12 months (a possible 42.65% upside). 3 analyst firms have reported ratings in the last year.
高盛於2023年8月10日報道了奇異基因組系統(納斯達克:OMIC)的最新目標價。這家分析公司將目標價定為1.00美元,預計OMIC將在12個月內上漲(可能上漲42.65%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Singular Genomics Sys (OMIC)?
Single Genology Sys(OMIC)的最新分析師評級是多少?
The latest analyst rating for Singular Genomics Sys (NASDAQ: OMIC) was provided by Goldman Sachs, and Singular Genomics Sys maintained their neutral rating.
單一基因組學系統(納斯達克:OMIC)的最新分析師評級由高盛提供,單一基因組學系統維持其中性評級。
When is the next analyst rating going to be posted or updated for Singular Genomics Sys (OMIC)?
Single Genology Sys(OMIC)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Singular Genomics Sys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Singular Genomics Sys was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Single Genonomy Sys的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Single Genology Sys的上一次評級是在2023年8月10日提交的,所以你應該預計下一次評級將在2024年8月10日左右的某個時候提供。
Is the Analyst Rating Singular Genomics Sys (OMIC) correct?
分析師對Single Genology Sys(OMIC)的評級正確嗎?
While ratings are subjective and will change, the latest Singular Genomics Sys (OMIC) rating was a maintained with a price target of $1.15 to $1.00. The current price Singular Genomics Sys (OMIC) is trading at is $0.70, which is out of the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Single Genology Sys(OMIC)評級保持不變,目標價在1.15美元至1.00美元之間。Single Genology Sys(OMIC)目前的交易價格為0.70美元,超出分析師的預測區間。